
### [NCIT:C7935](http://purl.obolibrary.org/obo/NCIT_C7935)
**Label:** Recurrent Kaposi Sarcoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.31%
- [NCIT:C53413](http://purl.obolibrary.org/obo/NCIT_C53413) (Malignant Oval Endothelial Cell) 51.72%
- [NCIT:C53405](http://purl.obolibrary.org/obo/NCIT_C53405) (Malignant Spindle Endothelial Cell) 51.72%
- [NCIT:C37092](http://purl.obolibrary.org/obo/NCIT_C37092) (Spindle Endothelial Cell) and [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 51.72%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 48.47%
- [NCIT:C47834](http://purl.obolibrary.org/obo/NCIT_C47834) (Malignant Endothelial Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 48.47%


